School Mental Health

, Volume 5, Issue 1, pp 48–57 | Cite as

Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey

  • Lynn K. KoegelEmail author
  • Anna M. Krasno
  • Howard Taras
  • Robert L. Koegel
  • William Frea
Original Paper


Prescription medications are commonly used for children with autism spectrum disorder (ASD); however, there is little research regarding how the effect of medication is monitored across settings once prescribed. The present study addressed this issue for children with ASD in school by administering a questionnaire to teachers of students with ASD who were and were not being given medication. Specifically, the questionnaire assessed the teachers’ knowledge about whether the child was being given medication, and whether behavior changes or side effects were being communicated in any way to the child’s family and prescribing physician. The results showed that for children who were being given medication, fewer than half of the teachers reported knowing the child was being given medication. For those children who were not being given medication, only 53 % of the teachers reported correct information for their students. Of the teachers who knew their students were being given medication, all reported that they were not conferring with the child’s prescribing physician regarding behavioral observations or side effects. Whether teachers are blind to the medication types and dosage the students are being given or not, some type of communication to physicians about the children’s behavior at school is important. Given the importance of monitoring medication for children with ASD, implications for system change, for professionals and for funding agencies, are discussed.


Medication Autism Autism spectrum disorder Monitoring medication Teachers Parents 


  1. Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15, 116–126.PubMedCrossRefGoogle Scholar
  2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association. (Text revision).Google Scholar
  3. Anderson, L., & Walcott, C. M. (2009). Issues in monitoring medication effects in the classroom. Psychology in the Schools, 46(9), 820–826.CrossRefGoogle Scholar
  4. Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1443–1450.PubMedCrossRefGoogle Scholar
  5. Castle, L., Aubert, R. E., Verbrugge, R. R., Khalid, M., & Epstein, R. S. (2007). Trends in medication treatment for ADHD. Journal of Attention Disorders, 10, 335–342.PubMedCrossRefGoogle Scholar
  6. Coghill, D. (2003). Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive-compulsive disorders, autism, Tourette’s and schizophrenia. Advances in Psychiatric Treatment, 9, 289–299.CrossRefGoogle Scholar
  7. Cohen, J. (1977). Statistical power analysis for the behavioral sciences. Orlando, FL: Academic Press, Inc.Google Scholar
  8. Dabrowska, A., & Pisula, E. (2010). Parenting stress and coping styles in mothers and fathers of pre-school children with autism and down syndrome. Journal of Intellectual Disabilities Research, 54(3), 266–280.CrossRefGoogle Scholar
  9. Ebensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 39, 1339–1349.CrossRefGoogle Scholar
  10. Farlow, L. J., & Snell, M. E. (1989). Teacher use of student instructional data to make decisions: Practices in programs for students with moderate to profound disabilities. Journal of the Association for Persons with Severe Handicaps, 14(1), 13–22.Google Scholar
  11. Foy, J. M., Kelleher, K. J., & Laraque, D. (2010). Enhancing pediatric mental health care: Strategies for preparing a primary care practice. Pediatrics, 125, S87–S108.PubMedCrossRefGoogle Scholar
  12. Fuchs, L. S., & Fuchs, D. (1986). Effects of systematic formative evaluation: A meta-analysis. Exceptional Children, 53(3), 199–208.PubMedGoogle Scholar
  13. Galinat, K., Barcalow, K., & Krivda, B. (2005). Caring for children with autism in the school setting. Journal of School Nursing, 21(4), 208–217.PubMedCrossRefGoogle Scholar
  14. Gerhard, T., Chavez, B., Olfson, M., & Crystal, S. (2009). National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder. Journal of Clinical Psychopharmacology, 29, 307–310.PubMedCrossRefGoogle Scholar
  15. Green, V., Pituch, K., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84.PubMedCrossRefGoogle Scholar
  16. Gringas, P., & McNicholas, F. (1999). Developing rational protocols for paediatric psychopharmacological prescribing. Child: Care, Health and Development, 25, 223–233.CrossRefGoogle Scholar
  17. Gringras, P. (2000). Practical paediatric psychopharmacological prescribing in autism. Autism, 4, 229–247.CrossRefGoogle Scholar
  18. Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for attention-deficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.Google Scholar
  19. Haile-Mariam, A., Bradley-Johnson, S., & Johnson, C. M. (2002). Pediatricians’ preferences for ADHD information from schools. School Psychology Review, 31, 94–105.Google Scholar
  20. Hall, H. R., & Graff, J. C. (2011). The relationships among adaptive behaviors of children with autism, family support, parenting stress, and coping. Issues in Comprehensive Pediatric Nursing, 34(1), 4–25.PubMedCrossRefGoogle Scholar
  21. Hastings, R. P., Kovshoff, H., Brown, T., Ward, N. J., Espinosa, F. D., & Remington, B. (2005). Coping strategies in mothers and fathers of preschool and school-age children with autism. Autism, 9(4), 377–391.PubMedCrossRefGoogle Scholar
  22. Koegel, R. L., & Koegel, L. K. (2012). The PRT pocket guide. Baltimore, MD: Brookes Publishing Company.Google Scholar
  23. Koelch, M., Schnoor, K., & Fegert, J. M. (2008). Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry, 21, 598–605.PubMedCrossRefGoogle Scholar
  24. Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry, 16, 97–112.PubMedCrossRefGoogle Scholar
  25. Liptak, G. S., Stuart, T., & Auinger, P. (2006). Health care utilization and expenditures for children with autism: Data from U.S. national samples. Journal of Autism and Developmental Disorders, 36, 871–879.PubMedCrossRefGoogle Scholar
  26. Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. B., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, e441–e448.PubMedCrossRefGoogle Scholar
  27. Matson, J. L., & Dempsey, T. (2008). Autism spectrum disorders: Pharmacotherapy for challenging behaviors. Journal of Developmental and Physical Disabilities, 20, 175–191.CrossRefGoogle Scholar
  28. McCracken, J. T. (2005). Safety issues with drug therapies for autism spectrum disorders. Journal of Clinical Psychiatry, 66, 32–37.PubMedGoogle Scholar
  29. McDonald, J. H. (2009). Handbook of biological statistics (2nd ed.). Baltimore, MD: Sparky House Publishing.Google Scholar
  30. Morgan, S., & Taylor, E. (2007). Antipsychotic drugs in children with autism. British Medical Journal, 334, 1069–1070.PubMedCrossRefGoogle Scholar
  31. Myers, S. M., & Johnson, C. P. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162–1182.PubMedCrossRefGoogle Scholar
  32. Oswald, P. D., & Sonenklar, N. A. (2007). Medication use among children with autism-spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348–355.PubMedCrossRefGoogle Scholar
  33. Pliszka, S. R., Lopez, M., Crismon, M. L., Toprac, M. G., Hughes, C. W., Emslie, G., et al. (2003). A feasibility study of the children’s medication algorithm project (CMAP) algorithm for the treatment of ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 279–287.PubMedCrossRefGoogle Scholar
  34. Posey, D. J., Sigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. The Journal of Clinical Investigation, 118(1), 6–14.PubMedCrossRefGoogle Scholar
  35. Raffin, C. (2001). A multidisciplinary approach to working with autistic children. Educational and Child Psychology, 18(2), 15–29.Google Scholar
  36. Robb, A. S. (2010). Managing irritability and aggression in autism spectrum disorders in children and adolescents. Developmental Disabilities Research Review, 16(3), 258–264.CrossRefGoogle Scholar
  37. Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, J. K., Marvin, A. R., & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008. Journal of Autism and Developmental Disorders, 40, 342–351.PubMedCrossRefGoogle Scholar
  38. Scahill, L., & Martin, A. (2005). Psychopharmacology. In F. R. Volkmar, R. Paul, A. Klin, & D. Cohen (Eds.), Handbook of Autism and pervasive developmental disorders (pp. 1102–1117). Hoboken, NJ: Wiley.Google Scholar
  39. Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., et al. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114(5), e634–e641.PubMedCrossRefGoogle Scholar
  40. Steinberg-Epstein, R., Book, T., & Wigal, S. B. (2011). Controversies surrounding pediatric psychopharmacology. Advances in Pediatrics, 58, 153–179.PubMedCrossRefGoogle Scholar
  41. Swanson, J., Lerner, M., March, J. S., & Gresham, F. (1999). Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Pediatric Clinics of North America, 46, 993–1009.PubMedCrossRefGoogle Scholar
  42. Troost, P. W., Lahuis, B., Steenhuis, M., Ketelaars, C. E., Buitelaar, J. K., van Engeland, H., et al. (2005). Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 44(11), 1137–1147.PubMedCrossRefGoogle Scholar
  43. Vereb, R. L., & DiPerna, J. C. (2004). Teachers’ knowledge of ADHD, treatments for ADHD, and treatment acceptability: An initial investigation. School Psychology Review, 33, 421–428.Google Scholar
  44. Volkmar, F. R., Lord, C., Bailey, A., Schultz, R. T., & Klin, A. (2004). Autism and pervasive developmental disorders. Journal of Child Psychology and Psychiatry, 45, 135–170.PubMedCrossRefGoogle Scholar
  45. Volkmar, F. R., Wiesner, L. A., & Westphal, A. (2006). Healthcare issues for children on the autism spectrum. Current Opinion in Psychiatry, 19, 361–366.PubMedCrossRefGoogle Scholar
  46. Weithorn, C. J., & Ross, R. (1975). Who monitors medication? Journal of Learning Disabilities, 8, 458–461.CrossRefGoogle Scholar
  47. Williamson, E. D., & Martin, A. (2010). Psychotropic medications in autism: Practical considerations for parents. Journal of Autism and Developmental Disorders, 42(6), 1249–1255.CrossRefGoogle Scholar
  48. Witwer, A., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15, 671–681.PubMedCrossRefGoogle Scholar
  49. Wolraich, M. L., Lambert, E. W., Bickman, L., Simmons, T., Doffing, M. A., & Worley, K. A. (2002). Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Development and Behavioral Pediatrics, 25, 41–47.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Lynn K. Koegel
    • 1
    Email author
  • Anna M. Krasno
    • 1
  • Howard Taras
    • 2
  • Robert L. Koegel
    • 1
  • William Frea
    • 3
  1. 1.Counseling, Clinical, and School Psychology Department, Koegel Autism Center, Graduate School of EducationUniversity of CaliforniaSanta BarbaraUSA
  2. 2.Pediatrics, Rady Children’s HospitalUniversity of CaliforniaSan DiegoUSA
  3. 3.Autism Spectrum TherapiesLos AngelesUSA

Personalised recommendations